Effects of Bromocriptine in Peripartum Cardiomyopathy: A Systematic Review and Meta-analysis

Peripartum cardiomyopathy (PPCM) is a rare but potentially life-threatening form of heart failure affecting women toward the end trimester of pregnancy, during delivery, or early postpartum period. Bromocriptine, a dopamine D2 agonist, has been used as an adjunctive treatment for PPCM with controversial benefits.

Source: Journal of Cardiac Failure - September 30, 2020 Category: Cardiology Authors: Veraprapas Kittipibul, Sunita Mahabir, Garly R. Saint Croix, Michael Ibrahim, Gabriel A. Hernandez, Sandra Chaparro Tags: 061 Source Type: research